Oct 8 (Reuters) - Philip Morris International Inc PM.N:
PHILIP MORRIS INTERNATIONAL URGES U.S. FDA ADVISORY COMMITTEE TO RECOMMEND CONTINUED MARKETING OF IQOS AS MODIFIED RISK PRODUCT
Further company coverage: PM.N
((Reuters.Briefs@thomsonreuters.com;;))